 |
 |
|
|
RESÚMENES FEBRERO 2007 |
Psychotic Disorders
& Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
Cambio de haloperidol a olanzapina en una muestra de pacientes peruanos
esquizofrénicos con extrapiramidalismo
Tamayo Jorge
Mario, Fernández Alberto, Holguín Jorge, Adrianzén Cecilia, Vílchez Luis,
Ruiz Eduardo, Saavedra Bertha
Arch Neurocien Mex 2006; 11(4):232-240
TEXTO
GRATUITO (previo registro)
Stability of
early-phase primary psychotic disorders with concurrent substance use and
substance-induced psychosis
CAROL L. M. CATON, DEBORAH S. HASIN, PATRICK E. SHROUT, ROBERT E. DRAKE,
BOANERGES DOMINGUEZ, MICHAEL B. FIRST, SHARON SAMET, BELLA SCHANZER
The British Journal of Psychiatry (2007) 190:
105-111
Risk of hip
fracture in patients with a history of schizophrenia
LOUISE HOWARD, GRAHAM
The British Journal of Psychiatry (2007) 190:
129-134:
Cancer risk among
parents and siblings of patients with schizophrenia
ITZHAK LEVAV, IRENA LIPSHITZ, ILYA NOVIKOV, INNA PUGACHOVA, ROBERT KOHN,
MICHA BARCHANA, A. PONIZOVSKY, HAIM WERNER
The British Journal of Psychiatry (2007) 190:
156-161
Paternal ages below or above 35 years old
are associated with a different risk of schizophrenia in the offspring
European Psychiatry. Volume 22, Issue 1, January 2007, Pages 22-26
Discontinuing and
Switching Antipsychotic Medications: Understanding the CATIE Schizophrenia
Trial
Weiden PJ
J Clin Psychiatry 2007;68(Suppl. 1):12-19
TEXTO
GRATUITO
Metabolic
Considerations in the Use of Antipsychotic Medications: A Review of Recent
Evidence
Newcomer JW
J Clin Psychiatry 2007;68(Suppl. 1):20-27
TEXTO
GRATUITO
Atypical
antipsychotic monitoring: A survey of patient knowledge and experience
Larkin
Feeney, Mary Mooney
Ir J Psych Med 2006; 23(3):
100-102
TEXTO GRATUITO
Antipsychotics
equivalent? CUtLASS renews the debate. Is
Robert J. Constantine, Rajiv Tandon
Curr Psychiatry. VOL. 6, NO. 2/FEBRUARY 2007:58
TEXTO GRATUITO
Cannabis and
cognitive dysfunction: Parallels with endophenotypes
of schizophrenia?
Nadia Solowij, Patricia T. Michie
J Psychiatry Neurosci
2007;32(1):30-52
TEXTO GRATUITO
Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week
placebo-controlled trial
J. Kane, F. Canas, M. Kramer, L. Ford, C. Gassmann-Mayer,
P. Lim and M. Eerdekens
Schizophrenia Research. Volume 90, Issues 1-3, February 2007, Pages 147-161
Cardiovascular and metabolic risk in outpatients with schizophrenia treated
with antipsychotics: Results of the CLAMORS Study
Julio Bobes, Celso Arango,
Pedro Aranda, Rafael Carmena,
Margarida Garcia-Garcia, Javier Rejas and on behalf
of the CLAMORS Study Collaborative Group
Schizophrenia Research. Volume 90, Issues 1-3, February 2007, Pages 162-173
Celecoxib as adjunctive therapy in
schizophrenia: A double-blind, randomized and placebo-controlled trial
Shahin Akhondzadeh, Maryam Tabatabaee, Homayoun Amini, Seyed Ali Ahmadi Abhari, Seyed Hesamedin Abbasi and Behnaz Behnam
Schizophrenia Research. Volume 90, Issues 1-3, February 2007, Pages 179-185
The burden of depressive symptoms in the
long-term treatment of patients with schizophrenia
Robert R. Conley, Haya Ascher-Svanum, Baojin Zhu, Douglas E. Faries and
Bruce J. Kinon
Schizophrenia Research. Volume 90, Issues 1-3, February 2007, Pages 186-197
Suicidality in schizophrenic patients with
and without obsessive-compulsive disorder
Levent Sevincok, Aybars Akoglu and Filiz Kokcu
Schizophrenia Research. Volume 90, Issues 1-3, February 2007, Pages 198-202
Plasma cortisol-dehydroepiandrosterone
(DHEA) ratios in schizophrenia and bipolar disorder
Peter Gallagher,
Stuart Watson, Margaret S. Smith, Allan H. Young and
Schizophrenia Research. Volume 90, Issues 1-3, February 2007, Pages 258-265
Pituitary volume in neuroleptic-naïve
schizophrenia: A structural MRI study
Ameet R. Upadhyaya, Rhonda El-Sheikh, Frank P. MacMaster,
Vaibhav A. Diwadkar and Matcheri S. Keshavan
Schizophrenia Research. Volume 90, Issues 1-3, February 2007, Pages 266-273
Effects of Gamma-Aminobutyric
Acid–Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia
Lara Menzies, Cinly Ooi, Shri
Kamath, John Suckling, Peter McKenna, Paul Fletcher,
Ed Bullmore, Caroline Stephenson
Arch Gen Psychiatry. 2007;64:156-167
Bilateral Deep Brain Stimulation of the Globus Pallidus to Treat Tardive Dyskinesia
Philippe Damier, Stéphane Thobois, Tatiana Witjas, Emmanuel Cuny, Philippe Derost, Sylvie Raoul, Patrick Mertens, Jean-Claude Peragut,
Jean-Jacques Lemaire, Pierre Burbaud,
Jean-Michel Nguyen, Pierre-Michel Llorca, Olivier Rascol, for the French Stimulation for Tardive
Dyskinesia (STARDYS) Study Group
Arch Gen Psychiatry. 2007;64:170-176
Effects of Donepezil
Adjunctive Treatment to Ziprasidone on Cognitive
Deficits in Schizophrenia: A Double-blind, Placebo-Controlled Study
Fagerlund B, Soholm B, Fink-Jensen A, Lublin H, Glenthoj BY
Clin Neuropharmacol. 2007
January/February;30(1):3-12
Impact of Splitting
Risperidone Tablets on Medication Adherence and on
Clinical Outcomes for Patients With Schizophrenia
Ellen M. Weissman, Cornelia Dellenbaugh
Psychiatr
Serv 58:201-206, February 2007
Correlates of
Adverse Childhood Events Among Adults With
Schizophrenia Spectrum Disorders
Stanley D. Rosenberg, Weili Lu, Kim T. Mueser, Mary Kay Jankowski, and Francine Cournos
Psychiatr
Serv 58:245-253, February 2007
Practical Aplication of Recent Antipsychotic Effectiveness Data
Lieberman et al.
J Clin Psychiatry 2007;68:151-162 [Academic Highlights]
TEXTO GRATUITO
Aripiprazole augmentation in the management
of residual symptoms in clozapine-treated outpatients
with chronic schizophrenia: An open-label pilot study
Charalampos I. Mitsonis, Nikolaos P. Dimopoulos, Panagiotis A.
Mitropoulos, Evangelia G. Kararizou,
Alexandra N. Katsa, Fivos
E. Tsakiris and Maria Nefeli
E. Katsanou
Improvement in antipsychotic-related
metabolic disturbances in patients with schizophrenia switched to ziprasidone
José Manuel Montes, Jose Luis Rodriguez, Eduardo Balbo, Pedro Sopelana,
Eloy Martin, Jose Antonio Soto, Jose Francisco
Delgado, Teresa Diez and Inmaculada
Villardaga
The effects of olanzapine
and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: A
double blind study
M. Jakovljevic, N. Pivac, A. Mihaljevic-Peles, M. Mustapic, M.
Relja, D. Ljubicic, D. Marcinko and D. Muck-Seler
Schizophrenia with prominent catatonic
features (‘catatonic schizophrenia’).II. Factor analysis of the catatonic
syndrome
Gabor S. Ungvari, William Goggins, Siu-Kau Leung and Jozsef Gerevich
Migration and schizophrenia
Selten,
Jean-Paul; Cantor-Graae,
Current Opinion in Psychiatry. 20(2):111-115, March 2007
Effectiveness of early
intervention in psychosis
Killackey, Eoin; Yung, Alison R
Current Opinion in Psychiatry. 20(2):121-125, March 2007
Tardive dyskinesia:
eliminated, forgotten, or overshadowed?
Remington,
Current Opinion in Psychiatry. 20(2):131-137, March 2007
Sexual dysfunction in
schizophrenia
Malik,
Peter
Current Opinion in Psychiatry.
20(2):138-142, March 2007
A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic
schizophrenia
Lee, Sae-Woom;
Lee, Jung-Goo; Lee, Bong-Ju;
Kim, Young Hoon
International Clinical Psychopharmacology. 22(2):63-68, March 2007
Insulin counter-regulatory factors, fibrinogen and
C-reactive protein during olanzapine administration:
effects of the antidiabetic metformin
Baptista, Trino;
Sandia, Ignacio; Lacruz, Anny; Rangel, Nairy; Mendoza, Soaira de;
Beaulieu, Serge; Contreras, Quilianio; Galeazzi, Tatiana; Vargas, Doritza
International Clinical Psychopharmacology. 22(2):69-76, March 2007
Efficacy and safety of risperidone
long-acting injectable in stable psychotic patients
previously treated with oral risperidone
Schmauss, Max; Sacchetti,
Emilio; Kahn, Jean-Pierre; Medori, Rossella
International Clinical Psychopharmacology. 22(2):85-92, March 2007
Electroconvulsive Therapy for Schizophrenia
Chanpattana, Worrawat
Current
Psychiatry Reviews, Volume 3, Number 1, February 2007, pp. 15-24(10)
Traumatic Brain Injury as a Risk Factor for Schizophrenia
Corcoran, Cheryl; Malaspina, Dolores
Current
Psychiatry Reviews, Volume 3, Number 1, February 2007, pp. 25-32(8)
Major Mental Disorders and Violence: A Critical Update
Joyal, Christian
C; Dubreucq, Jean-Luc; Gendron,
Catherine; Millaud, Frederic
Current
Psychiatry Reviews, Volume 3, Number 1, February 2007, pp. 33-50(18)
Aripiprazole
for Treatment-Resistant Schizophrenia: Results of a Multicenter,
Randomized, Double-Blind, Comparison Study Versus Perphenazine
John M. Kane, Herbert Y. Meltzer, William H.
Carson, Jr., Robert D. McQuade, Ronald N. Marcus, and
Raymond Sanchez, for the Aripiprazole Study Group
J Clin Psychiatry 2007;68:213-223
Melatonin in
Schizophrenic Outpatients With Insomnia: A
Double-Blind, Placebo-Controlled Study
P. N. Suresh Kumar, Chittaranjan
Andrade, Savita G. Bhakta,
and Nagendra M. Singh
J Clin Psychiatry 2007;68:237-241
Rapid Leptin
Elevation after Initiation of Olanzapine?
Hsuan-Chi Wang, Po See Chen, I Hui Lee, Yen Kuang Yang, Tzung Lieh Yeh,
Ru-Band Lu
Neuropsychobiology 2006;54:182-185
Lower levels of whole blood serotonin in
obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive
symptoms
Ning Ma,
Li-wen Tan, Qiang Wang, Ze-xuan Li and Ling-jiang Li
Psychiatry Research. Volume 150, Issue 1, 28 February 2007, Pages 61-69
Platelet serotonin and serum cholesterol
concentrations in suicidal and non-suicidal male patients with a first episode
of psychosis
Darko Marčinko, Nela Pivac, Marko Martinac, Miro Jakovljević, Alma Mihaljević-Peleš and Dorotea
Muck-Šeler
Psychiatry Research. Volume 150, Issue 1, 28 February 2007, Pages 105-108
Attenuating effect of reboxetine
on appetite and weight gain in olanzapine-treated
schizophrenia patients: a double-blind placebo-controlled study
Poyurovsky M, Fuchs C, Pashinian A,
Levi A, Faragian S, Maayan R, Gil-Ad I
Psychopharmacology (Berl). 2007
Feb 20; [Epub ahead of print]
Symptomatic remission in previously
untreated patients with schizophrenia: 2-year results from the
Novick D, Haro JM, Suarez D, Lambert M, Lepine JP, Naber D
Psychopharmacology (Berl). 2007
Feb 20; [Epub ahead of print]
Outcomes in Schizophrenia
Outpatients Treated with Amisulpride or Olanzapine
A. Hofer, M. A. Rettenbacher, M. Edlinger,
R. Huber, T. Bodner, G. Kemmler, G. Sachs,
W. W. Fleischhacker
Pharmacopsychiatry 2007; 40: 1-8
Valproic
Acid improves Psychotic Agitation without Influencing Plasma Risperidone Levels
in Schizophrenic Patients
R. Yoshimura, K. Shinkai, N. Ueda, J. Nakamura
Pharmacopsychiatry 2007;
40: 9-13
Blood
Glucose in Chronic Schizophrenic Patients Treated with Antipsychotics
Tilman Wetterling, Barbara Schneider, Bernhard Weber
A naturalistic,
9-month follow-up, comparing olanzapine and
conventional antipsychotics on sexual function and
hormonal profile for males with schizophrenia
Anna Maria Nicolai Costa,
Mauricio Silva de Lima, Marité Faria, Salomão Rodrigues Filho, Irismar Reis De
Oliveira, Jair de Jesus Mari
Journal of Psychopharmacology, Vol. 21, No. 2, 165-170
(2007)